Fig 4. How early treatment correlates with higher rebound probability.

a. Early treatments preserve more target cells and result in a longer duration between the end of N-R and the onset of an adaptive immune response, leading to a higher probability of an individual being classified as experiencing rebound. b. Later treatments preserve fewer target cells and result in a shorter duration between the end of N-R and the onset of an adaptive immune response, leading to a lower probability of an individual being classified as experiencing rebound.